Abstract
ABSTRACT Using a highly sensitive and specific radioimmunoassay for thyroid-stimulating hormone (TSH), basal serum TSH levels and the response to synthetic thyrotropin-releasing hormone (TRH) were evaluated in 21 patients with unequivocal hypothyroidism resulting from pituitary or hypothalamic lesions. Baseline TSH concentrations were undetectable in only 2, being normal (n = 9) or slightly elevated (n = 10) in the rest. Three of those with elevated levels had evidence of associated primary thyroid disease. Excluding these, the mean serum TSH concentration in the remaining 18 patients (3.4 ± 0.8 (sem) μU/ml) was significantly higher (p < 0.0005) than the mean of 75 euthyroid control subjects (1.0 ± 0.1 μU/ml). Patients with hypothalamic lesions generally had higher basal TSH levels than those with pituitary lesions. Treatment with thyroxine 0.1–0.3 mg/day led to suppression of the measured TSH values. Dilutions of sera containing normal and elevated TSH levels, showed parallelism with the standard curve (...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Journal of clinical endocrinology and metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.